For additional high-purity, third-party tested research compounds, visit our main shop page
Following these observations, clinical trials using GLP-1 therapies for the treatment of obesity showed stunning results, with treated patients losing an average of 12.4% of their initial body weight
Weve seen real success in our Semaglutide before and after stories
These data come from Cosmos, a dataset created in collaboration with a community of Epic health systems representing more than 277 million patient records from 1,500 hospitals and more than 36,000 clinics from all 50 US states, Lebanon, and Saudi Arabia
Brand names are referenced for educational context only and do not indicate that a specific branded product will be prescribed